335 related articles for article (PubMed ID: 31100495)
1. Growth hormone (GH) receptor (GHR)-specific inhibition of GH-Induced signaling by soluble IGF-1 receptor (sol IGF-1R).
Zhang Y; Gc S; Patel SB; Liu Y; Paterson AJ; Kappes JC; Jiang J; Frank SJ
Mol Cell Endocrinol; 2019 Jul; 492():110445. PubMed ID: 31100495
[TBL] [Abstract][Full Text] [Related]
2. Human GH receptor-IGF-1 receptor interaction: implications for GH signaling.
Gan Y; Buckels A; Liu Y; Zhang Y; Paterson AJ; Jiang J; Zinn KR; Frank SJ
Mol Endocrinol; 2014 Nov; 28(11):1841-54. PubMed ID: 25211187
[TBL] [Abstract][Full Text] [Related]
3. The role of prolactin receptor in GH signaling in breast cancer cells.
Xu J; Sun D; Jiang J; Deng L; Zhang Y; Yu H; Bahl D; Langenheim JF; Chen WY; Fuchs SY; Frank SJ
Mol Endocrinol; 2013 Feb; 27(2):266-79. PubMed ID: 23192981
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone signaling in human T47D breast cancer cells: potential role for a growth hormone receptor-prolactin receptor complex.
Xu J; Zhang Y; Berry PA; Jiang J; Lobie PE; Langenheim JF; Chen WY; Frank SJ
Mol Endocrinol; 2011 Apr; 25(4):597-610. PubMed ID: 21310852
[TBL] [Abstract][Full Text] [Related]
5. GHR/PRLR Heteromultimer Is Composed of GHR Homodimers and PRLR Homodimers.
Liu Y; Zhang Y; Jiang J; Lobie PE; Paulmurugan R; Langenheim JF; Chen WY; Zinn KR; Frank SJ
Mol Endocrinol; 2016 May; 30(5):504-17. PubMed ID: 27003442
[TBL] [Abstract][Full Text] [Related]
6. IGF-1R modulation of acute GH-induced STAT5 signaling: role of protein tyrosine phosphatase activity.
Gan Y; Zhang Y; Buckels A; Paterson AJ; Jiang J; Clemens TL; Zhang ZY; Du K; Chang Y; Frank SJ
Mol Endocrinol; 2013 Nov; 27(11):1969-79. PubMed ID: 24030252
[TBL] [Abstract][Full Text] [Related]
7. Functional collaboration of insulin-like growth factor-1 receptor (IGF-1R), but not insulin receptor (IR), with acute GH signaling in mouse calvarial cells.
Gan Y; Paterson AJ; Zhang Y; Jiang J; Frank SJ
Endocrinology; 2014 Mar; 155(3):1000-9. PubMed ID: 24302626
[TBL] [Abstract][Full Text] [Related]
8. Deletion of IGF-I receptor (IGF-IR) in primary osteoblasts reduces GH-induced STAT5 signaling.
Gan Y; Zhang Y; Digirolamo DJ; Jiang J; Wang X; Cao X; Zinn KR; Carbone DP; Clemens TL; Frank SJ
Mol Endocrinol; 2010 Mar; 24(3):644-56. PubMed ID: 20133448
[TBL] [Abstract][Full Text] [Related]
9. Subdomain 2, Not the Transmembrane Domain, Determines the Dimerization Partner of Growth Hormone Receptor and Prolactin Receptor.
Liu Y; Jiang J; Lepik B; Zhang Y; Zinn KR; Frank SJ
Endocrinology; 2017 Oct; 158(10):3235-3248. PubMed ID: 28977606
[TBL] [Abstract][Full Text] [Related]
10. Development of a novel ligand that activates JAK2/STAT5 signaling through a heterodimer of prolactin receptor and growth hormone receptor.
Langenheim JF; Chen WY
J Recept Signal Transduct Res; 2009; 29(2):107-12. PubMed ID: 19519175
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone and prolactin receptors in adipogenesis: STAT-5 activation, suppressors of cytokine signaling, and regulation of insulin-like growth factor I.
Fleenor D; Arumugam R; Freemark M
Horm Res; 2006; 66(3):101-10. PubMed ID: 16735796
[TBL] [Abstract][Full Text] [Related]
12. The role of prolactin and growth hormone in breast cancer.
Wennbo H; Törnell J
Oncogene; 2000 Feb; 19(8):1072-6. PubMed ID: 10713692
[TBL] [Abstract][Full Text] [Related]
13. Two wrongs can make a right: dimers of prolactin and growth hormone receptor antagonists behave as agonists.
Langenheim JF; Tan D; Walker AM; Chen WY
Mol Endocrinol; 2006 Mar; 20(3):661-74. PubMed ID: 16269515
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
15. Prolactin, growth hormone, and epidermal growth factor activate Stat5 in different compartments of mammary tissue and exert different and overlapping developmental effects.
Gallego MI; Binart N; Robinson GW; Okagaki R; Coschigano KT; Perry J; Kopchick JJ; Oka T; Kelly PA; Hennighausen L
Dev Biol; 2001 Jan; 229(1):163-75. PubMed ID: 11133161
[TBL] [Abstract][Full Text] [Related]
16. Prolactin induces up-regulation of its cognate receptor in breast cancer cells via transcriptional activation of its generic promoter by cross-talk between ERα and STAT5.
Kavarthapu R; Tsai Morris CH; Dufau ML
Oncotarget; 2014 Oct; 5(19):9079-91. PubMed ID: 25193864
[TBL] [Abstract][Full Text] [Related]
17. MSM enhances GH signaling via the Jak2/STAT5b pathway in osteoblast-like cells and osteoblast differentiation through the activation of STAT5b in MSCs.
Joung YH; Lim EJ; Darvin P; Chung SC; Jang JW; Do Park K; Lee HK; Kim HS; Park T; Yang YM
PLoS One; 2012; 7(10):e47477. PubMed ID: 23071812
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone (GH) binding and effects of GH analogs in transgenic mice.
Bartke A; Turyn D; Aguilar CC; Sotelo AI; Steger RW; Chen XZ; Kopchick JJ
Proc Soc Exp Biol Med; 1994 Jul; 206(3):190-4. PubMed ID: 8016152
[TBL] [Abstract][Full Text] [Related]
19. Activation of growth hormone receptors by growth hormone and growth hormone antagonist dimers: insights into receptor triggering.
Yang N; Langenheim JF; Wang X; Jiang J; Chen WY; Frank SJ
Mol Endocrinol; 2008 Apr; 22(4):978-88. PubMed ID: 18096690
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone- and prolactin-induced proliferation of insulinoma cells, INS-1, depends on activation of STAT5 (signal transducer and activator of transcription 5).
Friedrichsen BN; Galsgaard ED; Nielsen JH; Møldrup A
Mol Endocrinol; 2001 Jan; 15(1):136-48. PubMed ID: 11145745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
